Features of T cells causing H-2-restricted lethal graft-vs.-host disease across minor histocompatibility barriers

doi:10.1084/jem.155.3.872

This Article

	Full Text (PDF, 899K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Korngold, R.
	Articles by Sprent, J.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Korngold, R.
	Articles by Sprent, J.


Social Bookmarking

	What's this?

ARTICLES

Features of T cells causing H-2-restricted lethal graft-vs.-host disease across minor histocompatibility barriers

R Korngold and J Sprent

Evidence is presented that T cells that produce lethal graft-vs.-host disease (GVHD) to minor histocompatibility antigens (minor HA) comprise discrete subgroups of H-2K- and H-2D-restricted T cells; double negative selection of T cells in irradiated H-2 recombinant mice was used to separate these two subgroups. No evidence could be found that I- restricted T cells contributed to GVHD, either as effector cells or helper cells. The (unprimed) precursor cells for GVHD expressed the Thy- 1+, Lyt-1+/-2, Ia- phenotype. Studies in which H-2-semiallogeneic bone marrow chimeras were used as hosts for negative selection suggested that presentation of minor HA to T cells during the induction phase is controlled by marrow-derived cells; indirect evidence was obtained that these latter cells can "process" minor HA presented on H-2 different cells and thereby render the antigens immunogenic. Studies in which minor HA-different, H-2-compatible chimeras were re-irradiated and then injected with donor-vs.-host T cells suggested that the effector phase of lethal GVHD involves contact of antigen on non-marrow-derived cells.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

He, S., Cao, Q., Qiu, Y., Mi, J., Zhang, J. Z., Jin, M., Ge, H., Emerson, S. G., Zhang, Y., Zhang, Y. (2008). A New Approach to the Blocking of Alloreactive T Cell-Mediated Graft-versus-Host Disease by In Vivo Administration of Anti-CXCR3 Neutralizing Antibody. J. Immunol. 181: 7581-7592 [Abstract] [Full Text]
Matte-Martone, C., Liu, J., Jain, D., McNiff, J., Shlomchik, W. D. (2008). CD8+ but not CD4+ T cells require cognate interactions with target tissues to mediate GVHD across only minor H antigens, whereas both CD4+ and CD8+ T cells require direct leukemic contact to mediate GVL. Blood 111: 3884-3892 [Abstract] [Full Text]
Chakraverty, R., Sykes, M. (2007). The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia. Blood 110: 9-17 [Abstract] [Full Text]
Durakovic, N., Bezak, K. B., Skarica, M., Radojcic, V., Fuchs, E. J., Murphy, G. F., Luznik, L. (2006). Host-Derived Langerhans Cells Persist after MHC-Matched Allografting Independent of Donor T Cells and Critically Influence the Alloresponses Mediated by Donor Lymphocyte Infusions. J. Immunol. 177: 4414-4425 [Abstract] [Full Text]
Kaplan, D. H., Anderson, B. E., McNiff, J. M., Jain, D., Shlomchik, M. J., Shlomchik, W. D. (2004). Target Antigens Determine Graft-versus-Host Disease Phenotype. J. Immunol. 173: 5467-5475 [Abstract] [Full Text]
Zhang, Y., Joe, G., Zhu, J., Carroll, R., Levine, B., Hexner, E., June, C., Emerson, S. G. (2004). Dendritic cell-activated CD44hiCD8+ T cells are defective in mediating acute graft-versus-host disease but retain graft-versus-leukemia activity. Blood 103: 3970-3978 [Abstract] [Full Text]
Zhang, Y., Shlomchik, W. D., Joe, G., Louboutin, J.-P., Zhu, J., Rivera, A., Giannola, D., Emerson, S. G. (2002). APCs in the Liver and Spleen Recruit Activated Allogeneic CD8+ T Cells to Elicit Hepatic Graft-Versus-Host Disease. J. Immunol. 169: 7111-7118 [Abstract] [Full Text]
Cooke, K. R., Olkiewicz, K., Erickson, N., Ferrara, J. L.M. (2002). The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease. Innate Immunity 8: 441-448 [Abstract]
Shlomchik, W. D., Couzens, M. S., Tang, C. B., McNiff, J., Robert, M. E., Liu, J., Shlomchik, M. J., Emerson, S. G. (1999). Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting Cells. Science 285: 412-415 [Abstract] [Full Text]
Friedman, T. M., Gilbert, M., Briggs, C., Korngold, R. (1998). Repertoire Analysis of CD8+ T Cell Responses to Minor Histocompatibility Antigens Involved in Graft-Versus-Host Disease. J. Immunol. 161: 41-48 [Abstract] [Full Text]
MITSUYASU, R. T., CHAMPLIN, R. E., GALE, R. P., HO, W. G., LENARSKY, C., WINSTON, D., SELCH, M., ELASHOFF, R., GIORGI, J. V., WELLS, J., TERASAKI, P., BILLING, R., FEIG, S. (1986). Treatment of Donor Bone Marrow with Monoclonal Anti-T-Cell Antibody and Complement for the Prevention of Graft-Versus-Host Disease: A Prospective, Randomized, Double-Blind Trial. ANN INTERN MED 105: 20-26 [Abstract]